| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 09/26/2013 | US20130252978 Novel Hydrated Form of Erlotinib Free Base and a Process For Preparation Of Erlotinib Hydrochloride Polymorph Form A Substantially Free of Polymorph Form B |
| 09/26/2013 | US20130252975 Novel rock inhibitors |
| 09/26/2013 | US20130252964 Compounds And Methods For Treating Candidiasis And Aspergillus Infections |
| 09/26/2013 | US20130252963 Pyrimidinone compounds for use in the treatment of disease or conditions mediated by lp-pla2 |
| 09/25/2013 | EP2641902A1 Substituted pyrimidine ammonia compound and use thereof |
| 09/25/2013 | EP2640710A2 Crystalline pharmaceutically active ingredients |
| 09/25/2013 | EP2640709A2 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 09/25/2013 | CN103329299A Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same |
| 09/25/2013 | CN103328451A Compounds for the reduction of beta-amyloid production |
| 09/25/2013 | CN103328450A Crystalline pharmaceutically active ingredients |
| 09/25/2013 | CN103319422A New gefitinib crystal form and preparation method thereof |
| 09/25/2013 | CN103319421A Preparation method of pyribenzoxim belonging to pyrimidinylthiobenzoate herbicide |
| 09/25/2013 | CN103319420A Method for preparing 4,6-dihydroxypyrimidine |
| 09/25/2013 | CN103319419A Preparation method of 4-parafluorophenyl6-isopropyl-2-(N-methylmethanesulfamine)pyrimidine-5-carboxylic acid |
| 09/25/2013 | CN103319418A Method for preparing sulfamonomethoxine sodium |
| 09/25/2013 | CN103319408A Compounds for preventing and treating cardiovascular diseases |
| 09/25/2013 | CN101993420B Preparation method of 4-[(4,6-dihydroxyl-2-pyrimidinyl)amino] cyanobenzene |
| 09/24/2013 | US8541594 Herbicides |
| 09/24/2013 | US8541575 3,4-diarylpyrazoles as protein kinase inhibitors |
| 09/24/2013 | US8541434 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 09/24/2013 | US8541428 Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof |
| 09/24/2013 | US8541423 Methods and compositions for treating pain |
| 09/24/2013 | US8541420 Ketolide compounds having antimicrobial activity |
| 09/24/2013 | US8541419 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as CRTH2 antagonists |
| 09/24/2013 | US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/24/2013 | US8541402 Viral polymerase inhibitors |
| 09/24/2013 | CA2722028C 5-hydroxypyrimidine-4-carboxamide compound |
| 09/24/2013 | CA2655146C Benzamide derivatives and uses related thereto |
| 09/24/2013 | CA2576993C Bisaryl-sulfonamides |
| 09/24/2013 | CA2474277C 2,4-pyrimidinediamine compounds and their uses |
| 09/19/2013 | WO2013137371A1 Novel pyrimidine compound and medicine comprising same |
| 09/19/2013 | WO2013136110A1 Process for the preparation of bosentan monohydrate |
| 09/19/2013 | WO2013136073A1 Agricultural chemicals |
| 09/19/2013 | WO2013135176A1 Aminoquinazoline derivative and use thereof in preparing anti-malignant tumor medicament |
| 09/19/2013 | US20130245263 Process for the preparation of pyrimidine derivatives |
| 09/19/2013 | US20130245262 Process for the preparation of pazopanib using novel intermediate |
| 09/19/2013 | US20130245261 Process for preparing pan-cdk inhibitors of the formula (i), and intermediates in the preparation |
| 09/19/2013 | US20130245260 Neprilysin inhibitors |
| 09/19/2013 | US20130245257 Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst |
| 09/19/2013 | US20130245256 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 09/19/2013 | US20130245051 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
| 09/19/2013 | US20130245033 Amide compounds |
| 09/19/2013 | US20130245019 Acrylomido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 09/19/2013 | US20130245018 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use |
| 09/18/2013 | EP2639226A1 Anti-infective pyrimidines and uses thereof |
| 09/18/2013 | EP2638179A1 Non metal tanning |
| 09/18/2013 | EP2638018A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors |
| 09/18/2013 | EP2637502A1 Mutant-selective egfr inhibitors and uses thereof |
| 09/18/2013 | CN1578779B Small organic molecule regulators of cell proliferation |
| 09/18/2013 | CN103313725A Adsorption of immunopotentiators to insoluble metal salts |
| 09/18/2013 | CN103304493A 2-fluoro-aniline quinazoline tumour positron imaging agents as well as preparation method and application thereof |
| 09/18/2013 | CN103304492A Synthesis method of EGFR (epidermal growth factor receptor) inhibitor Dacomitinib |
| 09/18/2013 | CN103304491A Preparation method of gefitinib |
| 09/18/2013 | CN103304490A Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark |
| 09/18/2013 | CN103304489A Pyrimidine benzamide compound and preparation and application thereof |
| 09/18/2013 | CN103304488A Preparation method of optical pure 2-(1-hydroxylethyl)-5-hydroxylpyrimidine |
| 09/18/2013 | CN103304487A Organic semiconductor material containing pyrimidine, preparation method thereof and organic light-emitting device |
| 09/18/2013 | CN103304428A Amine-based compound, organic light-emitting diode including the same, and organic light-emitting apparatus including the amine-based compound |
| 09/18/2013 | CN102336717B Quinazoline derivative |
| 09/18/2013 | CN102153481B Application of thionyl chloride and alcohol as selective deacylation reagents for N-aryl fatty amide or N-heterocyclic fatty amide |
| 09/18/2013 | CN102046605B Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 09/18/2013 | CN101328138B Preparation of trimethoprim |
| 09/17/2013 | US8536331 N-alkoxyamides of 6-(trisubstituted phenyl)-4-aminopicolinates and their use as selective herbicides for crops |
| 09/17/2013 | US8536186 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 09/17/2013 | US8536185 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
| 09/17/2013 | US8536184 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 09/17/2013 | US8536151 Process for preparing lamivudine polymorph form |
| 09/17/2013 | CA2570903C N-hydroxyamide derivatives and use thereof |
| 09/17/2013 | CA2498644C Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 09/12/2013 | WO2013134061A1 Phenicol antibacterials |
| 09/12/2013 | WO2013131424A1 4-quinazoline amine derivative and application thereof |
| 09/12/2013 | US20130237704 Drug for Treating Liver Lesions Caused by the Action of Chemical or Biological Agents |
| 09/12/2013 | US20130237553 Multicomponent system of resuvastatin calcium salt and sorbitol |
| 09/12/2013 | US20130237502 Phenicol antibacterials |
| 09/12/2013 | US20130237422 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides |
| 09/11/2013 | EP2635565A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors |
| 09/11/2013 | EP2635285A1 Heteroaryl compounds and uses thereof |
| 09/11/2013 | CN103298794A Pyridine compounds and aza analogues thereof as TYK2 inhibitors |
| 09/11/2013 | CN103298793A Method for the preparation of high-purity pharmaceutical intermediates |
| 09/11/2013 | CN103288871A Intermediate for preparing dihydroxy acid HMG-CoA reductase inhibitor, and preparation method and applications thereof |
| 09/11/2013 | CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/11/2013 | CN103288762A Preparation method of ketanserin intermediate 3-chloroethyl-2,4(1H,3H) quinazolinedione |
| 09/11/2013 | CN103288761A New method for synthesizing 1,2,3,4-quinazoline-2,4-diketone derivative |
| 09/11/2013 | CN103288760A Preparation method of canertinib (I) |
| 09/11/2013 | CN103288759A Method for preparing dacomitinib |
| 09/11/2013 | CN103288758A Preparation method of dacomitinib (I) |
| 09/11/2013 | CN103288757A Preparation method of 6-amino-7-hydroxyl-3,4-dihydroquinazoline-4-ketone |
| 09/11/2013 | CN103288756A Methanol solvate of quinazoline intermediate and preparation method thereof |
| 09/11/2013 | CN103288755A Midbody 4-chlorine-6-amino-7-hydroxy-quinazoline for synthesizing nilotinib type antineoplastic drug and preparation method for midbody 4-chlorine-6-amino-7-hydroxy-quinazoline |
| 09/11/2013 | CN103288754A Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same |
| 09/11/2013 | CN103288753A Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors |
| 09/11/2013 | CN103288752A Cinnamic amide derivatives, their preparation methods and their application in preparation of bleeding stopping and stasis dissolving medicines |
| 09/11/2013 | CN103288751A Preparation method of high-purity nifekalant hydrochloride |
| 09/11/2013 | CN103288750A Novel amino sulfonylurea compounds |
| 09/11/2013 | CN103288749A Amino sulfonylurea compounds capable of being used as herbicides |
| 09/11/2013 | CN103288748A Method for preparing 4,6-dichloro-5-amino-2-(propylsulfanyl)pyrimidine |
| 09/11/2013 | CN103288747A 6-Cyclohexylmethyl-2-aromatic ring carbonyl substituted N-DABO compounds, and synthetic method and use thereof |
| 09/11/2013 | CN103288746A Preparation method of 2-azyl-5-bromopyrimidine |
| 09/11/2013 | CN103288683A Method for preparing nicarbazin through one-pot process |